Ellington Financial (EFC) buy case: mispriced mREIT with 12.9% yield, 30% upside to $15.73. Explore valuation, ROE, liquidity ...

Kohl's Corporation KSS is likely to witness top and bottom-line declines when it reports fourth-quarter fiscal 2025 earnings on March 10, before the market opens. The Zacks Consensus Estimate for ...

The J. M. Smucker Company (NYSE:SJM) is included among the 14 Value Stocks to Buy with High Dividend Yields. On February 27, TD Cowen raised its price recommendation on The J. M. Smucker Company (NYSE ...

The average long-term mortgage rate in the U.S. fell below 6% this week, reaching the benchmark for the first time in nearly four years as affordability for homebuyers has improved in the last few ...

Melvin Trotter, on Florida's death row for the brutal 1986 murder of Virgie Langford during a convenience store robbery in Palmetto, was executed by lethal injection Feb. 24, at Florida State Prison ...

Masco is well-positioned for cyclical recovery, supported by pricing power, cost initiatives, and long-term structural demand drivers. MAS trades at 17.9x FY26 EPS, a discount to Sherwin-Williams, ...

ICE said an agent with its Homeland Security Investigations unit fired the fatal shots during a traffic incident after Martinez failed to follow law enforcement instructions while agents were ...

Harry is a Writer, Editor, and Content Strategist from Portsmouth, United Kingdom. He started writing about games as the Editor of his university website, and in the ten years since, he has been ...

Zillow Group (NASDAQ:Z) is one of the best stocks under $50 to invest in. On February 12, Susquehanna lowered its price target for Zillow Group from $80 to $50 and maintained a Neutral rating. The ...

Violent crime fell dramatically in 2025, in what experts expect to be the year with the sharpest drop in homicides in recorded history. The decline, detailed in two recent reports of major U.S. cities ...

RSV hospitalizations at Northwell’s Cohen Children’s Medical Center fell from 250–300 per month in late 2024 to fewer than 50 in 2025. The decline follows the rollout of FDA-approved RSV vaccines and ...